<h1 id="abm-category-home-title">Guaranteed CRISPR Knockout Cell Line Generation</h1>
<nav id="abm-navbar" class="navbar navbar-fixed-top abm-navbar abm-affix abm-category-navbar-relative hidden-xs">
	<div class="abm-container-fluid">
		<div id="abmNavbar" class="collapse navbar-collapse abm-navbar-collapse">
			<ul class="nav navbar-nav navbar-6">
				<li><a href="#abm-category-section1">Overview</a></li>
				<li><a href="#abm-category-section2">Service Details</a></li>
				<li><a href="#abm-category-section3">Additional Info</a></li>
				<li><a href="#abm-category-section4">Related Products</a></li>
				<li><a href="#abm-category-section5">Documents &amp; FAQS</a></li>
				<li><a href="#abm-category-section7">Citations</a></li>
			</ul>
		</div>
	</div>
</nav>
<div id="abm-category-section1" class="abm-container-fluid">
	<div class="row">
		<div class="col-sm-8 col-xs-12">
			<div><strong>abm</strong> offers the first ever <strong>100% Guaranteed</strong> CRISPR Knockout Cell Line Generation Service to our clients who want to have full confidence in their knockout models. We understand how obtaining successful knockout models can have a significant impact on your research.<br /><br /></div>
			<div>
				<strong>Our Promise:</strong>
				<ul>
					<li>Delivery or no charge</li>
					<li>100% guaranteed full-allelic knockout at the protein level</li>
					<li>2 cryovials provided per clone</li>
					<li>90% cell viability</li>
				</ul>
			</div>
			Our 100% Guaranteed Service is risk-free - you pay nothing if we do not deliver.<br /><br />
			<div id="guaranteeTitle"><strong>The Only Service that Guarantees 100% Gene Editing</strong></div>
			<br />
			<table>
				<tbody>
					<tr>
						<td style="text-align: center;" width="28%"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-100-percent-success-icon.png" /></td>
						<td width="6%"></td>
						<td style="text-align: center;" width="28%"><img src=" /pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-risk-free-icon.png" /></td>
						<td width="6%"></td>
						<td style="text-align: center;" width="28%"><img src=" /pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-research-confidence-icon.png" /></td>
					</tr>
					<tr>
						<td colspan="5" height="10px"></td>
					</tr>
					<tr>
						<td style="text-align: center;"><strong>100% Success</strong><br /> 100% Guaranteed full allelic knockout at the protein level</td>
						<td></td>
						<td style="text-align: center; align: top;"><strong>Risk-Free</strong><br /> Delivery or no charge<br /><br /></td>
						<td></td>
						<td style="text-align: center;"><strong>Research Confidence</strong><br /> Have full confidence in your knockout models</td>
					</tr>
				</tbody>
			</table>
			<br />
			<p><a href="/guaranteed-crispr-knockout-cell-line-generation-inquiry" target="_blank"><button class="custom-service-inquire-button-normal" style="float: left;">Inquire</button></a></p>
			<br /><br />
		</div>
		<div class="col-sm-4  col-xs-12">
			<div class="mini-box2">
				<div class="banners">
					<div><a href="https://www.abmgood.com/marketing/knowledge_base/CRISPR_Cas9_Introduction_Part1.php"> <img src="/pub/media/catalog/customservice/custom_crispr_sgrna_lentiviral_vectors_&amp;_viruses/Resources_Introduction-to-CRISPR.png" alt="Introduction to CRISPR" width="100%" /> <br /> </a> <strong>Introduction to CRISPR - Knowledge Base</strong></div>
				</div>
				<br /> <span class="bluetext"><b>Additional Resources:</b></span>
				<ul class="grey-list grey-link">
					<li><a href="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/CRISPR-Stable-KO-Service-Case-Study.pdf" target="_blank">CRISPR Stable KO Service Case Study</a></li>
					<li><a href="https://www.abmgood.com/CRISPR-product-selector/product-selector-form.php" target="_blank">CRISPR Experimental Design Tool</a></li>
				</ul>
			</div>
		</div>
	</div>
</div>
<div id="abm-category-section2">
	<div class="abm-container-fluid">
		<div class="row">
			<div class="col-lg-8">
				<h3 class="abm-perfect-h3">Service Details</h3>
				<b class="subtitle">Our 100% Guaranteed Service Package (C508)</b> <br /> Each phase of the service comes with milestone-based reports to keep you fully updated on the status of your project. <strong>abm</strong>'s 3 phase KO cell line generation process:<br /><br />
				<table>
					<tbody>
						<tr>
							<td style="text-align: center;" width="25%"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-phase-1-icon.png" /></td>
							<td width="75%"><span style="color: #f60; font-size: 16px;">Strategy &amp; Design</span><br /> Consult our specialists on your project: choose from our list of cells* or use your own cell line model<br /> Selection of target site and prediction of off-target sites</td>
						</tr>
						<tr>
							<td colspan="2" height="10px"></td>
						</tr>
						<tr>
							<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-phase-2-icon.png" /></td>
							<td width="65%"><span style="color: #f60; font-size: 16px;">CRISPR/Cas9 Genome Editing</span><br /> sgRNA vector design and construction<br /> Gene transfer efficiency optimization<br /> Delivery of CRISPR/Cas9 machinery into host cells</td>
						</tr>
						<tr>
							<td colspan="2" height="10px"></td>
						</tr>
						<tr>
							<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-phase-3-icon.png" /></td>
							<td width="65%"><span style="color: #f60; font-size: 16px;">Selection, Validation, and Delivery</span><br /> Clonal screening and selection<br /> Validation of knockout by Sanger sequencing and Western blot<br /> Expansion and cryopreservation of selected clones<br /> Microbial/sterility testing</td>
						</tr>
					</tbody>
				</table>
				<br />
				<div>
					<table class="bootstrap-table bootstrap-table-hover abm-service-table abm-perfect-table1">
						<thead>
							<tr>
								<th>Add-On Services</th>
								<th>Unit</th>
								<th>CAT. NO.</th>
								<th>PRICE</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td>Cell Line of Choice for Gene Editing**</td>
								<td>1 Cell Line</td>
								<td>C141</td>
								<td>$<span class="customServicePriceGeoIP">800.00</span></td>
							</tr>
							<tr>
								<td>WT Control Cell Line Expressing Cas9 for Comparison</td>
								<td>1 Cell Line</td>
								<td>C142</td>
								<td>$<span class="customServicePriceGeoIP">1590.00</span></td>
							</tr>
							<tr>
								<td>Additional Clones</td>
								<td>1 Clone</td>
								<td>C143</td>
								<td>$<span class="customServicePriceGeoIP">250.00</span></td>
							</tr>
							<tr>
								<td>Additional Vials of Delivered Cells^^^</td>
								<td>1 Vial</td>
								<td>C144</td>
								<td>$<span class="customServicePriceGeoIP">80.00</span></td>
							</tr>
							<tr>
								<td>Off-Target Analysis by Whole Genome Sequencing</td>
								<td>1 Clone</td>
								<td>C146</td>
								<td>$<span class="customServicePriceGeoIP">4000.00</span></td>
							</tr>
							<tr>
								<td>Cell Line Authentication:<br />STR Profiling of 1 WT Parental Cell Line &amp; 1 Knock-Out Cell Line Clone</td>
								<td>1 Service</td>
								<td>C287</td>
								<td>$<span class="customServicePriceGeoIP">150.00</span></td>
							</tr>
						</tbody>
					</table>
				</div>
				<p><a href="/guaranteed-crispr-knockout-cell-line-generation-inquiry" target="_blank"><button class="custom-service-inquire-button-normal" style="float: right;">Inquire</button></a></p>
				<br /><br />
				<div style="font-size: 13px; color: grey;">**Choose from HEK293, HEK293T, A549, HeLa, MDCK, A375, HepG2, HT1080 or U87MG. These cell lines are available as Cas-9 expressing versions or parental versions. Cas9 expressing version will be used by default. If the parental version is preferred, please request prior to order placement.<br /> #Customer is required to provide at least 2 million cells, 1L of propagation media/any special coated flasks if needed (if cells need DMEM or RPMI, <strong>abm</strong> will supply media). Also, the cell line must tolerate single cell cloning and display adequate transfection and transduction efficiency.<br /> ##Pre-validated antibody needs to be provided by customer with appropriate positive control (preferably with supporting data).<br /> ^All “add on” services need to be indicated prior to order placement as the project design will need to be finalized prior to start of the service.<br /> ^^ Final Lead time may vary depending on actual growth rate of cell line while expanding from single cell.<br /> Please note that if the gene to be knocked-out may be essential to cell survival, it is up to the end-user to proceed with the services. <strong>abm</strong> is unable to guarantee cell survival in these cases and will only attempt to rescue the clones under these conditions. <strong>abm</strong> is not accountable for cell survival if rescuing the clones (instructions to be provided customers) is unsuccessful.</div>
			</div>
			<div class="col-lg-4"></div>
		</div>
	</div>
</div>
<div id="abm-category-section3" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Additional Info</h3>
			<b class="subtitle">Our Basic Vs. Our 100% Guaranteed Service:</b> <br />
			<table>
				<tbody>
					<tr>
						<td style="text-align: center; font-weight: bold;" width="49%">Basic Service (<a class="orange-link" href="/contract-research-cro-services/crispr-genome-editing-services/crispr-stable-knockout-cell-line" target="blank">C208</a>)</td>
						<td width="2%"></td>
						<td style="text-align: center;" width="49%"><span style="color: #f60; font-size: 16px; font-weight: bold;">100% Guaranteed Service (C508)</span></td>
					</tr>
					<tr>
						<td colspan="3" height="10px"></td>
					</tr>
					<tr>
						<td>
							<table>
								<tbody>
									<tr>
										<td style="text-align: center;" width="20%"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-gray-checkmark-icon.png" /></td>
										<td width="80%">Sanger Sequencing confirmation of knockout</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-gray-checkmark-icon.png" /></td>
										<td>Single gene knockouts for diploid loci only provided as hemizygous pools or monoclonal clone</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-gray-checkmark-icon.png" /></td>
										<td>2 cryovials/clone with &gt;90% viability</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td></td>
										<td></td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td></td>
										<td></td>
									</tr>
								</tbody>
							</table>
						</td>
						<td></td>
						<td>
							<table>
								<tbody>
									<tr>
										<td style="text-align: center;" width="20%"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-green-checkmark-icon.png" /></td>
										<td width="80%">100% Guaranteed Knockout (delivery or no charge)</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-green-checkmark-icon.png" /></td>
										<td>Sanger Sequencing confirmation of knockout</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-green-checkmark-icon.png" /></td>
										<td>Western Blot confirmation of full-allelic knockout at the protein level</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-green-checkmark-icon.png" /></td>
										<td>Single gene knockouts provided as monoclonal clone</td>
									</tr>
									<tr>
										<td colspan="2" height="12px"></td>
									</tr>
									<tr>
										<td style="text-align: center;"><img src="/pub/media/catalog/customservice/Guaranteed-CRISPR-KO-Cell-Line-Generation-Service-green-checkmark-icon.png" /></td>
										<td>2 cryovials/clone with &gt;90% viability</td>
									</tr>
								</tbody>
							</table>
						</td>
					</tr>
				</tbody>
			</table>
			<div>
				<a class="collapsed" href="#collapseOne" data-toggle="collapse" data-parent="#accordion"><b class="subtitle">CRISPR Stable KO Service Case Study</b><i class="fa fa-angle-down OrderAngleDown" style="padding-left: 0.4em; font-size: 3rem;"></i></a><br />
				<div id="collapseOne" class="panel-collapse collapse" style="border-left: none;">
					<div>
						<strong>Using CRISPR to develop a biallelic LIF knockout in Mouse Colon Carcinoma Cells</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>LIF locus in a Mouse Colon Carcinoma Cell Line, was knocked out using CRISPR targeted genome editing.</li>
							<li>Surveyor assay and sequencing results showed genome editing.</li>
							<li>After monoclonal selection biallelic knockout was confirmed by sequencing.</li>
						</ul>
						<br /> <strong>Phase #1: Cas9 and sgRNA Delivery</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>Three sgRNA were designed against mouse LIF locus (Mus musculus, NM_008501). Software analysis was performed to ensure the sgRNA had no predicted off targets binding sites. The selected sgRNA design was then cloned into the pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro All-in-One lentivector (Figure 1).</li>
							<li>Recombinant Lentiviruses were packaged using abm’s second generation Lentiviral packaging system. A multiplicity of infection (MOI) of 5 was used to transduce the cells.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro-NEW.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 1. pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro lentivector is an all-in-one vector for co-expressing sgRNA and Cas9 in mammalian cells. Expression of sgRNA is driven by the U6 promoter, a strong constitutive Pol III promoter. An SFFV promoter drives expression of the Cas9-2A-Puro cassette. By using the Cas9-2A-Puro cassette, cells can be directly screened for expression of Cas9, as they will be resistant to Puromycin.</i><br /><br /> <strong>Phase #2: First Round of Colony Screening for Edited Clones</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>Cell colonies are isolated after puromycin selection. Genomic DNA was extracted and the surveyor assay was performed to confirm genomic editing of the LIF locus.</li>
							<li>A single band in a surveyor assay at the wild-type (WT) size indicates no editing has occurred; two smaller bands (that sum to the length of the WT) indicate editing has taken place.</li>
							<li>The surveyor assay (Figure 2) indicated that Colony 3 and 6 were edited; colony 2 was not edited; and colony 1 was inconclusive.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/Surveyor.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 2. The surveyor assay indicated that Colony 3 and 6 were edited; colony 2 was not edited; and colony 1 was inconclusive.</i><br /><br /> <strong>Phase #3: Sequence Analysis of the Edited Colonies</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>PCR products from Colonies 3 and 6 were further analyzed via Sanger Sequencing to determine the nature of the knockout (Figure 3).</li>
							<li>For colony 3 only one mutant sequence was detected, indicating that these cells are likely only heterozyotic knockouts. In colony 6 two different mutant sequences were detected.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/Sequence-Alignment 1.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 3. For colony 3 only one mutant sequence was detected, indicating that these cells are likely only heterozyotic knockouts. In colony 6 two different mutant sequences were detected.</i><br /><br /> <strong>Phase #4: Second Round of Selection for Monoclonal Biallelic Knockout Clones</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>Colony 6 was serial diluted into 96 well plates for monoclonal selection. Genomic DNA was extracted from these clones (i.e. 6a, 6b..), PCR amplified, cloned and sequenced.</li>
							<li>Of the colony 6 clones, sequencing showed that only clone 6a had a frameshift mutation in both alleles (Figure 4). A frameshift mutation disrupts the open reading frame, resulting in nonsense mediated decay of mRNA transcript.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/Sequence-Alignment 2.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 4. Clones 6a, 6b and 6d all showed biallelic editing. Only clone 6a had frame shift mutations in both alleles. No WT sequences were detected in all subclones.</i><br />
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>Further sequencing of clone 6a confirmed that only two mutant alleles were present, the 2 bp and 4 bp deletions, and that no WT or other mutations were detected (Figure 5).</li>
						</ul>
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/Sequence-Alignment 3.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 5. Further sequencing of 6a confirmed biallelic knock-out. No WT sequences were detected.</i><br /><br /> <strong>Phase #5: Confirmation of Knockout by Next Generation Amplicon Sequencing</strong>
						<ul style="list-style-type: disc; padding-left: 0px;">
							<li>With next generation sequencing hundreds of thousands of alleles can be sequenced at once, resulting in a more robust dataset. By contrast Sanger sequencing is only feasible for 1-100 clones and therefore it can miss a large proportion of the population.</li>
							<li>Next generation sequencing was performed at each stage of selection to evaluate knockout (Figure 6). Before editing, only WT sequences were observed. After the first round of selection colony 6 showed a mixture of edited (70%) and WT (30%) sequences. Finally after monoclonal selection, clone 6a showed only edited sequences with no WT alleles present.</li>
						</ul>
						<br />
						<div>
							<p class="banners abm-category-workflow"><a href="javascript:void(0)"><img src="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/NGS-KO.png" alt="Workflow" /></a></p>
						</div>
						<i>Figure 6. Next Generation Sequencing for CRISPR Knockout screening. A) Before knockout only WT sequences are detected. B) After Cas9 and sgRNA delivery, the first round of selection shows a mixed distribution of indel and WT sequences. C) After the second round of selection only knockouts remain.</i>
					</div>
				</div>
			</div>
			<div>
				<a class="collapsed" href="#collapseTwo" data-toggle="collapse" data-parent="#accordion"><b class="subtitle">Additional Information &amp; MTA</b><i class="fa fa-angle-down OrderAngleDown" style="padding-left: 0.4em; font-size: 3rem;"></i></a><br />
				<div id="collapseTwo" class="panel-collapse collapse" style="border-left: none;">Orders of this service are subjected to the completion of a signed Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at <a class="orange-link" href="technical@abmgood.com">technical@abmgood.com</a>. The end user acknowledges that the Materials provided under abm’s MTA does not grant a license for commercial use or imply any ownership rights or any intellectual property rights relating to the Materials.<br /><br /> Please note that if the gene to be knocked out may be essential to cell survival, it is up to the end-user to proceed with the services. <strong>abm</strong> is unable to guarantee cell survival in these cases and will only attempt to rescue the clones under these conditions. <strong>abm</strong> is not accountable for cell survival if rescuing the clones (instructions to be provided customers) is unsuccessful. If customer chooses to proceed, <strong>abm</strong> will provide a hemizygous pool as the default deliverable to compensate for any lethal effects (unless otherwise requested).</div>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section4" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Related Products</h3>
			<div class="col-xs-12 col-sm-6 col-md-6 col-lg-6">
				<div class="row">
					<div class="module">
						<ul class="htmlcontent-home">
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/contract-research-cro-services/crispr-genome-editing-services/crispr-stable-knockout-cell-line"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="orange-link" href="/contract-research-cro-services/crispr-genome-editing-services/crispr-stable-knockout-cell-line"> CRISPR Stable Knockout Cell Line Generation </a></div>
									</div>
								</div>
							</li>
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/contract-research-cro-services/crispr-genome-editing-services/crispr-stable-knock-in-cell-line"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="orange-link" href="/contract-research-cro-services/crispr-genome-editing-services/crispr-stable-knock-in-cell-line"> CRISPR Stable Knockin Cell Line Generation Service </a></div>
									</div>
								</div>
							</li>
						</ul>
					</div>
				</div>
			</div>
			<div class="col-xs-12 col-sm-6 col-md-6 col-lg-6">
				<div class="row">
					<div class="module">
						<ul class="htmlcontent-home">
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/contract-research-cro-services/crispr-genome-editing-services/crispr-bacterial-genome-editing-service"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="orange-link" href="/contract-research-cro-services/crispr-genome-editing-services/crispr-bacterial-genome-editing-service"> CRISPR Bacterial Genome Editing Service </a></div>
									</div>
								</div>
							</li>
							<li class="col-xs-6 col-sm-6 col-md-6">
								<div class="banners">
									<div class="serviceimages" style="text-align: left;">
										<a href="/contract-research-cro-services/crispr-genome-editing-services/crispr-gene-or-mirna-lncrna-deletion-service"> <img src="/pub/media/catalog/category/imgs/perfect_page/Related-Products-tube.png" /> <br /> </a>
										<div class="abm-custom-service-image-title"><a class="orange-link" href="/contract-research-cro-services/crispr-genome-editing-services/crispr-gene-or-mirna-lncrna-deletion-service"> CRISPR Gene Deletion and miRNA/lncRNA Knockout Service </a></div>
									</div>
								</div>
							</li>
						</ul>
					</div>
				</div>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section5" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Documents</h3>
			<div>
				<ul class="cleanlist">
					<li><img src="/pub/media/catalog/category/imgs/perfect_page/PDF.png" /> <a class="black-link doclinks" href="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/CRISPR-Stable-KO-Service-Case-Study.pdf">CRISPR Stable KO Service Case Study</a></li>
					<li><img src="/pub/media/catalog/category/imgs/perfect_page/PDF.png" /> <a class="black-link doclinks" href="/pub/media/catalog/customservice/guaranteed-crispr-ko-cell-line-generation/Guaranteed-CRISR-Stable-Knockout-Cell-Line-Generation-Service-Feb-2018.pdf">CRISPR Stable KO Service Form</a></li>
				</ul>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section6" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">FAQs</h3>
			<b class="black-link"><i>Coming Soon</i></b>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>
<div id="abm-category-section7" class="abm-container-fluid">
	<div class="row">
		<div class="col-lg-8">
			<h3 class="abm-perfect-h3">Citations</h3>
			<div>
				<table>
					<tbody>
						<tr>
							<td><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/ncomms9371">01</a></span></td>
							<td>Kang, Y. J. et al. "Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling." Nat. Commun. (2015) 6:8371 <a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/ncomms9371">doi: 10.1038/ncomms9371</a></td>
						</tr>
						<tr>
							<td><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1940-6207.CAPR-15-0338">02</a></span></td>
							<td>Jiang, G. et al. "Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis." Cancer Prev Res. Published Online First April 14, 2016.<a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1940-6207.CAPR-15-0338">doi: 10.1158/1940-6207.CAPR-15-0338</a></td>
						</tr>
						<tr>
							<td width="5%"><span class="citations-num"><a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1136/gutjnl-2015-309359">03</a></span></td>
							<td width="95%">Okugawa, Y. et al. "Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer." Gut (2015)<a class="orange-link" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1136/gutjnl-2015-309359">doi:10.1136/gutjnl-2015-309359</a></td>
						</tr>
					</tbody>
				</table>
			</div>
		</div>
		<div class="col-lg-4"></div>
	</div>
</div>